Evidence map›Paper›PMID 42234713›Full record

ArticlePLoS genetics2026

Barrier-to-autointegration factor protects against the cGAS-STING response to chromatin bridges.

Laura Chastant, Karine Normandin, Firas El-Mortada, Marc J Servant, Vincent Archambault

Abstract read
In one paragraph

Article in PLoS genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Laura ChastantInstitute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada.
Karine NormandinInstitute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada.
Firas El-MortadaFaculté de Pharmacie, Université de Montréal, Montréal‌‌, Québec, Canada.
Marc J ServantFaculté de Pharmacie, Université de Montréal, Montréal‌‌, Québec, Canada.ORCID https://orcid.org/0000-0003-2014-4127
Vincent ArchambaultInstitute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada.ORCID https://orcid.org/0000-0002-2857-7667

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cellular damage or stress can lead to disorganization, mislocalization or damage to self-DNA that can activate intracellular innate immune response mechanisms. Micronuclei, such as can occur following mitotic defects, have been proposed as a source of DNA capable of activating the cGAS-STING pathway, resulting in IRF3-dependent proinflammatory transcription. However, to what extent micronuclei per se or other concurrent defects contribute to the cGAS-STING response remains unclear. To better understand the ability of post-mitotic defects to induce this response, we compared the effects resulting from inhibition of the Spindle-Assembly Checkpoint (through MPS1 inhibition) or interference with nuclear reassembly (through inactivation of BAF). We found that combining both perturbations synergistically enhances the cGAS-STING response. This effect is not due to an increase in post-mitotic nuclear deformations including micronucleation and lobulation but instead correlates with an increase in destabilized chromatin bridges resulting in structures that potently recruit cGAS. Our results suggest that by stabilizing chromatin bridges, BAF contributes to preventing their degeneration into cGAS-activating chromatin structures. This work helps better understand how the innate immune system detects mitotic defects.

Indexed as

cGAS-STING Signaling PathwayChromatinDNA-Binding ProteinsMembrane ProteinsNuclear ProteinsCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseDNA DamageHeLa CellsHumansImmunity, InnateInterferon Regulatory Factor-3MitosisNucleotidyltransferasesSignal TransductionSTING ProteinBANF1 protein, humancGAS protein, humanChromatinCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseDNA-Binding ProteinsInterferon Regulatory Factor-3IRF3 protein, humanMembrane ProteinsNuclear ProteinsNucleotidyltransferasesSTING1 protein, humanSTING Protein

Identifiers

PMID42234713
PMCPMC13258145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.